Headlines Expert Newsletters Covid-19 Specialties Trending Feeds Videos

Mashup Score: 1

OncLive

Expert oncologist Giuseppe Curigliano, MD, PhD, reflects on the updated results of the HER2CLIMB study evaluating tucatinib against placebo, each in combination with trastuzumab